nti_article_04

Nanotechnology Commercialization Group

Many of the nanotechnology inventions submitted to the Nanocommercialization Group (NCG) may be at too early a stage for licensing or investment consideration.

With that in mind, the Program to Support Translational Research (PSTR) fund provides financial support to characterize, advance the development, demonstrate the commercial potential of, or otherwise increase the commercial value of such inventions.
To be considered for funding, the intellectual property must be approved by the NCG. Consideration for funding is based on assessment of the following:

  • Commercial potential
  • Technical merit
  • Patent protection
  • Likelihood of achieving objectives with the resources provided
  • Ability of the funded studies to add significant value to the technology and/or to significantly improve its attractiveness for licensing or investment

Click here for information about IP and Licensing through the NCG.

For more information, contact:

Erli Chen, Ph.D.
University of Pennsylvania
Director, Nanotechnology Commercialization Group
chen@ctt.upenn.edu
(215) 898-9272

Why Is Small So Big?

Nanotechnology deals with products and processes that are measured in almost unbelievably small increments called “nanometers”—one billionth of a meter.

At the nanoscale, materials differ from larger objects in their physical, chemical and biological properties; therefore, they lend themselves to new and improved materials, systems and devices. Nanotechnology is behind the development of such diverse advancements as:

  1. Drug Delivery
  2. Biofiltration and Separation sciences
  3. Improved coatings for medical devices

Thanks to rapid advances in this exciting new field, we now have the tools and talents to manipulate materials on the molecular scale—a technology literally changing the world as we know it.